Healthcare Services

Global Anosmia Industry Trends and Market Growth Forecast for 2026–2030

March 30, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Large Is The Anosmia Market Projected To Become By 2030 Based On Its 2026 Valuation?

The anosmia market has experienced strong growth in recent years. It is anticipated to grow from $3.86 billion in 2025 to $4.23 billion in 2026, at a CAGR of 9.4%. This growth is linked to a higher incidence of virus-induced anosmia, increased awareness of olfactory disorders, wider availability of diagnostic tools, expansion of ENT specialty care, and improved reporting of sensory impairments.

The anosmia market is expected to grow strongly, reaching $6.07 billion by 2030 at a CAGR of 9.5%. Growth is attributed to increased research in olfactory nerve regeneration, adoption of new therapies, expansion of post-infectious care programs, rising demand for quality-of-life treatments, and growing clinical trial activity. Key trends include a stronger focus on regenerative treatments, increased use of smell training programs, adoption of targeted pharmacological therapies, expansion of diagnostic testing and imaging, and improved management of post-viral recovery.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18224&type=smp

Which Market Drivers Are Supporting The Expansion Of The Anosmia Market?

The rising occurrence of neurological disorders is anticipated to propel the growth of the anosmia market. Neurological disorders affect the brain, spinal cord, and nerves, and their prevalence is increasing due to aging populations and higher rates of chronic conditions such as diabetes and hypertension. These disorders can impair the olfactory system, leading to a loss of smell. For instance, in March 2023, the Alzheimer’s Association reported that 6.7 million Americans aged 65 and above are living with Alzheimer’s dementia, with projections rising to 13.8 million by 2060. Consequently, the increasing prevalence of neurological disorders is driving the anosmia market.

What Segment Groups Are Identified Within The Anosmia Market?

The anosmia market covered in this report is segmented –

1) By Type: Idiopathic Anosmia, Congenital Anosmia

2) By Treatment: Therapies, Medications

3) By End User: Hospitals, Clinics, Other End Users

Subsegments:

1) By Idiopathic Anosmia: Partial Idiopathic Anosmia, Complete Idiopathic Anosmia

2) By Congenital Anosmia: Isolated Congenital Anosmia, Syndromic Congenital Anosmia (Associated With Other Conditions Or Syndromes)

What Trends Are Advancing Progress In The Anosmia Market?

Major companies in the anosmia market are focusing on advanced delivery technologies such as soft-mist nasal sprays to improve drug absorption and target the olfactory region more effectively. This technology uses controlled droplet size and low velocity to enhance therapeutic outcomes. For instance, in April 2025, Cyrano Therapeutics completed enrollment in its Phase 2 FLAVOR trial for CYR-064, a soft-mist nasal spray designed for post-viral smell loss. The formulation includes a phosphodiesterase inhibitor and uses advanced spray systems to ensure precise delivery to the olfactory region.

Which Companies Hold Significant Positions In The Anosmia Market?

Major companies operating in the anosmia market are Cyrano Therapeutics, Regeneron Pharmaceuticals, Novartis AG, GlaxoSmithKline PLC, Otsuka Pharmaceutical Co Ltd, Bayer AG, AstraZeneca PLC, Eli Lilly and Company, Pfizer Inc, Sanofi SA, NeuroNascent Inc, Immunome Therapeutics, Olfactory Therapeutics Ltd, ENT Therapeutics Inc, NeuroSense Therapeutics LLC, SmellSense Bio, Olfactricity Therapeutics, Sensory Neurogenics Inc, Olfaxion Biotech, SmellGen Therapeutics, Post-Viral Sensory Recovery Inc, Hyposmia Therapeutics LLC

Read the full anosmia market report here:

https://www.thebusinessresearchcompany.com/report/anosmia-global-market-report

How Is The Anosmia Market Distributed Across Key Geographic Regions?

North America was the largest region in the anosmia market in 2025. Asia-Pacific is expected to be the fastest-growing region in the market going forward. The regions covered in the anosmia market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Anosmia Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=18224&type=smp

Browse Through More Reports Similar to the Global Anosmia Market 2026, By The Business Research Company

Aplastic Anemia Global Market Report

https://www.thebusinessresearchcompany.com/report/aplastic-anemia-global-market-report

Hyperlipidemia Global Market Report

https://www.thebusinessresearchcompany.com/report/hyperlipidemia-global-market-report

Anoscope Global Market Report

https://www.thebusinessresearchcompany.com/report/anoscope-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795